Biotechnology·Finance·Investing·News The Astonishing 945% Surge: Is Monopar Therapeutics’ Cash Strategy the Key to Its Success? Monopar Therapeutics experienced a remarkable 945% surge in share price over the past year, attributed to strategic cash management rather than revenue by Marques Jivaro 3 weeks ago
Flexsteel Industries’ Bold Moves Amid Trade Turmoil: Sustaining Growth and Innovating Through Uncertainty 1 day ago
Unlocking Warren Buffett’s Billion-Dollar Secret: How Dividends Power Berkshire Hathaway’s Financial Dominance 3 days ago
Heartbreaking Farewell: Kelly Ripa and Mark Consuelos’ Touching Tribute to Their Beloved Dog Chewie February 13, 2025